<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2905245379
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2001
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        VAQTA 25U SYRINGE I.M
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED)
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        25
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        U
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intramuscular use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Suspension for injection in pre-filled syringe
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        0
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Pre-filled syringe
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Biological
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store in a refrigerator (2°c – 8°c)
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        74.50
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="MERCK SHARP AND DOHME LLC" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            MERCK SHARP AND DOHME LLC
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 360]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Farouk, Maamoun Tamer & CO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            MERCK SHARP & DOHME
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J07BC02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Vaqta Paediatric is one of a general group of medicines called vaccines. Vaccines are used to protect against infectious diseases. They work by causing the body to produce its own protection against the targeted disease.</p><p>&nbsp;</p><p>This vaccine helps to protect against hepatitis A infection.</p><p>&nbsp;</p><p>Hepatitis A is a virus that attacks the liver, which can be caught from food or drink that contains the virus. Symptoms of hepatitis A include a yellowing of the skin and eyes (jaundice) and feeling generally unwell.</p><p>&nbsp;</p><p>When an injection of this vaccine is given, the body&rsquo;s natural defences will produce protection (antibodies) against the hepatitis A infection. However, it usually takes 2 to 4 weeks after receiving the injection before you or your child will be protected.</p><p>&nbsp;</p><p>This vaccine will not protect against other viruses that infect the liver (such as hepatitis B, hepatitis C or hepatitis E). This vaccine protects against hepatitis A but cannot cause a hepatitis A infection.</p><p>&nbsp;</p><p>The vaccination may not work properly if the person to be vaccinated is already infected with the hepatitis A virus.</p><p>&nbsp;</p><p>Vaqta Paediatric is for children from 12 months old up to 17 years old. This vaccine is not suitable for children under 12 months of age or adults aged 18 years and over.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not use Vaqta Paediatric:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; if you or your child is allergic to the active substance or any of the other ingredients of Vaqta Paediatric (listed in section 6) or to neomycin or formaldehyde (see section &#39;Warnings and precautions&#39;).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; if you or your child is ill with a high temperature. The vaccination should be delayed until you or your child has recovered.</p><p>&nbsp;</p><p>Warnings and precautions</p><p>Talk to your doctor, pharmacist or nurse before Vaqta Paediatric is given:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; if you or your child has ever had an allergic reaction to a previous dose of Vaqta Paediatric. This vaccine may contain traces of an antibiotic called neomycin and a substance called formaldehyde, both of which are used during vaccine production and may be present in the vaccine in trace amounts.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; if you or your child has a poor or reduced immune system, due to:</p><p>&ndash;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; corticosteroids, cytotoxic drugs or radiotherapy. Your doctor or nurse may wait until the treatment has finished.</p><p>&ndash;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; HIV (human immunodeficiency virus infection) or any disease that affects the immune system. The vaccine may not protect as well as it protects people whose immune system is healthy.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; if you or your child has any problems with the blood that causes easy bruising or bleeding for a long time after minor cuts. Your doctor or nurse may still advise that you or your child should have Vaqta Paediatric but extra care is needed because of the risk of bleeding at the injection site. Your doctor or nurse may give Vaqta Paediatric as an injection under the skin instead of into muscle (see section 3) to try to reduce the risk of deep bleeding.</p><p>The container of this medicinal product contains latex rubber. May cause severe allergic reactions.</p><p>&nbsp;</p><p>As with other vaccines, Vaqta Paediatric may not completely protect all persons who are vaccinated.</p><p>&nbsp;</p><p>Please tell your doctor if you or your child have had a history of jaundice or have lived in an area where hepatitis A is common. Your doctor will determine whether you or your child should be tested for hepatitis A antibodies prior to vaccination.</p><p>&nbsp;</p><p>Other medicines and VAQTA Paediatric</p><p><strong>&nbsp;</strong></p><p>Tell your doctor or pharmacist if you or your child is taking, has recently taken or might take any other medicines (or other vaccines).</p><p>&nbsp;</p><p>This vaccine can be given at the same time as any of the following provided that they are given in different parts of the body (for example another arm or leg) and are not mixed in the same syringe.</p><p>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; Measles, mumps, rubella and varicella (chickenpox) virus vaccines,</p><p>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; Pneumococcal 7-valent conjugate vaccine,</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; Polio vaccine (Inactivated),</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; Diphtheria toxoid, tetanus toxoid, acellular pertussis, and <em>Haemophilus influenzae </em>b vaccines,</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; Immunoglobulins (antibodies obtained from blood donors)</p><p>&nbsp;</p><p>In adults, Vaqta may be given at the same time as yellow fever and polysaccharide typhoid vaccines.</p><p>&nbsp;</p><p>Pregnancy, breast-feeding and fertility</p><p>If you or your child is pregnant or breast-feeding, think you or your child may be pregnant or is planning to have a baby, ask your doctor or pharmacist for advice whether you or your child should receive the vaccine.</p><p>Driving and using machines</p><p>There are no data to suggest that Vaqta Paediatric affects the ability to drive or operate machinery.</p><p>&nbsp;</p><p>VAQTA Paediatric contains sodium</p><p>This medicine contains less than 1mmol sodium (23mg) per dose, that is to say essentially &lsquo;sodium-free&rsquo;.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The vaccine will be injected by a doctor or nurse who has been trained in the use of vaccines and who is equipped to deal with any rare severe allergic reaction to the injection.</p><p>&nbsp;</p><p>Short term protection against hepatitis A is achieved within 2 to 4 weeks after receiving this vaccination.</p><p>&nbsp;</p><p>Long term protection against hepatitis A requires a second dose (booster) injection of an inactivated hepatitis A vaccine. This is usually given between 6 and 18 months after the first dose. Healthy children who have had two doses have been found to have antibody levels for at least 10 years. It is predicted that hepatitis A antibodies will remain at least 25 years after vaccination.</p><p>Safety and effectiveness in infants &lt; 12 months of age have not been established.</p><p>&nbsp;</p><p>Method of administration</p><p>The doctor or nurse will shake the syringe immediately before use and check that the liquid is white and cloudy and that there are no large particles.</p><p>&nbsp;</p><p>The vaccine is given as an injection into a muscle in the upper outer part of the arm (deltoid muscle). The muscle in the outer thigh region may be used in children if the deltoid muscle is not sufficiently developed. Your doctor or nurse will avoid giving you or your child the injection either into the skin or into a blood vessel. Children who are at risk of bleeding a lot after an injection (see section 2) may sometimes be given Vaqta</p><p>&nbsp;</p><p>Paediatric as an injection under the skin but not into muscle to try to reduce the risk of bleeding.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines and vaccines, this vaccine can cause side effects, although not everybody gets them.</p><p>As with all vaccines, allergic reactions, in rare cases leading to shock, may occur. These reactions may include:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hives</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; difficulty in breathing</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swelling of the face, tongue and throat</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dizziness</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; collapse</p><p>When these signs or symptoms occur they usually develop very quickly after the injection is given and while you or your child is still in the clinic or doctor&rsquo;s surgery. <strong>If any of these symptoms occur after leaving the place where you or your child&rsquo;s injection was given, contact a doctor IMMEDIATELY.</strong></p><p><strong>&nbsp;</strong></p><p>Side effects reported in children aged 12 months to 23 months</p><p><strong>&nbsp;</strong></p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Frequency of side effects</strong></p></td><td style="vertical-align:top"><p><strong>Side effects</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very common: may affect more than 1 in 10 children</p></td><td style="vertical-align:top"><p>injection-site pain/ tenderness and injection-site redness</p></td></tr><tr><td style="vertical-align:top"><p>Common: may affect up to 1 in 10 children</p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; injection-site swelling, injection-site warmth, injection-site bruising</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fever</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; irritability</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; diarrhoea</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon: may affect up to 1 in 100 children</p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; decreased or loss of appetite</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; trouble sleeping, sleepiness, feeling of tiredness-drowsiness, or lack of energy, restlessness</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; crying</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; runny nose, cough, nasal congestion</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; vomiting</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rash, diaper rash</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling unwell</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; injection-site lump, injection-site rash</p></td></tr><tr><td style="vertical-align:top"><p>Rare: may affect up to 1 in 1,000 children</p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; multiple allergies</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dehydration</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; agitation, nervousness, fear, screaming</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dizziness, headache, loss of balance</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; eyelid margin crusting</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; asthma, blocked airways, sneezing, runny or itchy nose, mouth and</p></td></tr></tbody></table><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>throat pain</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; nausea, stomach pain/discomfort, excessive gas in the stomach or bowel, frequent bowel movements, belching, infantile spitting up, constipation, discoloured faeces</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rash, itching and redness of the skin, blisters, clammy or warm skin, sweating</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflamed joints</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; at injection-site: bleeding, itching, discoloration, lump formation or an itchy rash; pain, discomfort</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fatigue, abnormality with manner of walking, feeling hot</p></td></tr><tr><td style="vertical-align:top"><p>Not known:</p><p>frequency cannot be estimated from the available data</p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Guillain-Barr&eacute; syndrome (muscle weakness, abnormal sensations, tingling in the arms, legs and upper body)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; thrombocytopenia (reduction in blood platelets which increases risks of bleeding and bruising</p></td></tr></tbody></table><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>Side effects reported in children aged 2 years to 17 years</strong></p><p><strong>&nbsp;</strong></p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Frequency of side effects</strong></p></td><td style="vertical-align:top"><p><strong>Side effects</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very common: may affect more than 1 in 10 children</p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp; injection-site pain and tenderness</p></td></tr><tr><td style="vertical-align:top"><p>Common: may affect up to 1 in 10 children</p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; headache</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; injection-site warmth, redness and swelling, fever, bleeding under the skin at the injection site (ecchymosis)</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon: may affect up to 1 in 100 children</p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; irritability</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dizziness</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; stomach ache, vomiting, diarrhoea, nausea</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rash, itching</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; arm pain (in the injected limb), joint pain, muscle pain</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; weakness/tiredness, injection-site itching and pain/soreness</p></td></tr><tr><td style="vertical-align:top"><p>Rare: may affect up to 1 in 1,000 children</p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; loss of appetite</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; nervousness</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sleepiness, abnormal skin sensations such as tingling</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ear ache</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; flushing</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; runny or blocked nose, cough</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hives, sweating</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; stiffness</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hardness (induration) at the injection-site, flu-like illness, chest pain, pain, warmth, injection-site scab, stiffness/ tightness and stinging</p></td></tr><tr><td style="vertical-align:top"><p>Not known:</p><p>frequency cannot</p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp; Guillain-Barr&eacute; syndrome (muscle weakness, abnormal sensations, tingling in the arms, legs and upper body)</p></td></tr></tbody></table><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>be estimated from</p><p>the available data</p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp; thrombocytopenia (reduction in blood platelets which increases risks of bleeding and bruising)</p></td></tr></tbody></table><p><strong>&nbsp;</strong></p><p>Reporting of side effects</p><p>If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the National Pharmacovigilance and Drug Safety Centre (NPC). SFDA).</p><p>By reporting side effects you can help provide more information on the safety of this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this vaccine out of the sight and reach of children.</p><p>&nbsp;</p><p>The vaccine should not be used after the expiry date (Exp) which is stated on the carton and syringe label.</p><p>&nbsp;</p><p>The vaccine must be stored in a refrigerator between 2&deg;C and 8&deg;C (making sure that it does not freeze) so that the vaccine keeps its effectiveness.</p><p>&nbsp;</p><p>Do not use this vaccine if you notice that it has an unusual appearance (see section 6) or contains particulate matter.</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active ingredient is: Inactivated hepatitis A virus (produced on MRC-5 human diploid cells, adsorbed on amorphous aluminium hydroxyphosphate sulfate).</p><p>&nbsp;</p><p>One dose (0.5 mL) contains 25U hepatitis A virus (inactivated) adsorbed on amorphous</p><p>aluminium hydroxyphosphate sulfate (0.225 milligram as aluminium).</p><p>&nbsp;</p><p>The other ingredients are:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sodium borate</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sodium chloride</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; water for injections</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                A pre-filled syringe or vial containing 0.5 millilitre (one dose) of the vaccine. The vaccine is available in single packs of the vial or pre-filled syringe with or without a needle.
Not all presentations may be marketed.
 
After thorough agitation, Vaqta Paediatric is an opaque white suspension.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Marketing Authorisation Holder</p><p>Merck Sharp &amp; Dohme B.V.</p><p>Waarderweg 39, 2031 BN Haarlem, The Netherlands.</p><p>&nbsp;</p><p>Manufacturer</p><p>Merck, Sharp &amp; Dohme LLC., Sumneytown Pike, P.O. Box 4, West Point, PA, USA.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in December 2020.

To report side effects:
•	Saudi Arabia: 
The National Pharmacovigilance Centre (NPC):
SFDA Call Center: 19999
E-mail: npc.drug@sfda.gov.sa
Website: https://ade.sfda.gov.sa

•	Other GCC States: 
Please contact the relevant competent authority.
This is a Medicament
•	Medicament  is  a  product  which  affects  your  health  and  its  consumption  contrary  to Instructions are dangerous for you.
•	Follow strictly the doctor’s prescription, the method of use and the instructions of the pharmacist who sold the medicament.
•	The doctor and the pharmacist are the experts in medicines, their benefits and risks.
•	Do not by yourself interrupt the period of treatment prescribed for you.
•	Do not repeat the same prescription without consulting your doctor.
•	Keep all medicaments out of reach of children.

Council of Arab Health Ministers  
 Union of Arab Pharmacists

This patient information leaflet is approved by the Saudi Food & Drug Authority. 

            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">ينتمي فاكتا الأطفال إلى مجموعة كاملة من الأدوية تسمى اللقاحات. وتستخدم اللقاحات في الوقاية من الأمراض المُعدية. فهي تعمل عن طريق حث الجسم على إنتاج حمايته الخاصة ضد المرض المستهدف.</p><p dir="RTL">يساعد هذا اللقاح على الوقاية من عدوى التهاب الكبد الوبائي أ.</p><p dir="RTL">التهاب الكبد الوبائي أ هو فيروس يهاجم الكبد، ويمكن أن ينتقل من خلال الطعام أو الشراب المُلوّث بالفيروس. وتشمل أعراض التهاب الكبد الوبائي أ اصفرار الجلد والعينين (اليرقان) والشعور العام بالتوعك.</p><p dir="RTL">عندما يُحقن هذا اللقاح، تقوم الدفاعات الطبيعية في الجسم بإنتاج حماية (الأجسام المضادة) ضد عدوى التهاب الكبد الوبائي أ. ولكن ، يستغرق الجسم مدة 2-4 أسابيع عادة قبل أن تحصل أنت أو طفلك على الحماية بعد التطعيم.</p><p dir="RTL">لن يحمي هذا اللقاح ضد الفيروسات الأخرى التي تصيب الكبد (مثل التهاب الكبد الوبائي بي ، التهاب الكبد الوبائي سي أو التهاب الكبد الوبائي إي). هذا اللقاح يحمي من التهاب الكبد الوبائي ولكن لا يمكن أن يسبب عدوى التهاب الكبد الوبائي أ.</p><p dir="RTL">قد لا يعمل التطعيم بشكل صحيح إذا كان الشخص المُراد تطعيمه مصابًا بالفعل بفيروس التهاب الكبد الوبائي أ.</p><p dir="RTL">فاكتا الأطفال مُعد للأطفال بدءًا من عمر 12 شهرا حتى 17 سنة. هذا اللقاح غير مناسب للأطفال دون سن 12 شهرا من العمر أو للبالغين الذين يبلغون 18 سنة من العمر فأكثر.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تستخدم فاكتا الأطفال إذا:</strong></p><p dir="RTL">&bull; كان لديك أو لدى طفلك حساسية نحو المادة الفعالة أو نحو أيّ من المكونات الأخرى في فاكتا الأطفال (المُدرجة في الفقرة رقم 6) أو نحو النيومايسين أو الفورمالدهيد (انظر فقرة &quot;المحاذير والاحتياطات&quot;).<br />&bull; كنت أنت أو طفلك مريضا ولديك حمّى عالية. يجب تأجيل التطعيم حتى تستعيد أنت أو طفلك عافيتك.</p><p dir="RTL"><strong>المحاذير والإحتياطات</strong><br />تحدث مع طبيبك أو الصيدلي أو الممرض قبل إعطاء فاكتا <strong>الأطفال </strong>:<br />&bull; إذا سبق وتعرّضت أنت أو طفلك لرد فعل تحسسي مع جرعة سابقة من فاكتا الأطفال. قد يحتوي هذا اللقاح على آثار لمضاد حيوي يُسمى النيومايسين و مادة تسمى الفورمالديهايد، وكلاهما يستخدم أثناء إنتاج اللقاح وقد يتواجدان في اللقاح بكميات ضئيلة.<br />&bull; إذا كان لديك أو لدى طفلك جهاز مناعي ضعيف أو منخفض ، وذلك بسبب:<br />&nbsp;&nbsp;&nbsp;- الكورتيكوستيرويدات، الأدوية السّامّة للخلايا &quot;العلاج الكيميائي&quot; &nbsp;أو العلاج الإشعاعي. قد ينتظر طبيبك أو ممرضتك حتى انتهاء العلاج.<br />&nbsp;&nbsp; - عدوى فيروس نقص المناعة البشري (إش أي في) أو أي مرض يؤثر على الجهاز المناعي. قد لا يحمي اللقاح هذه الفئة من المرضى ، كما يحمي الأشخاص الذين يتمتعون بجهاز مناعي سليم.<br />&bull; إذا كان لديك أو لدى طفلك أي مشاكل في الدم تُؤدي إلى حدوث الكدمات أو النزيف بسهولة ولفترة طويلة بعد تعرّضك لجروح طفيفة. هنا قد ینصح طبیبك أو ممرضك في إعطائك أنت أو طفلك فاكتا الأطفال ولكن مع أخذ المزيد من العناية بسبب خطر حدوث النزیف في موضع الحقن. قد يعطيك طبيبك أو &nbsp;ممرضك فاكتا الأطفال كحقنة تحت الجلد بدلا من حقنة في العضل (انظر الفقرة رقم 3) في محاولة للحد &nbsp;من خطر حدوث نزيف عميق.</p><p dir="RTL">تحتوي &nbsp;عبوة هذا المنتج الطبي على مطاط اللاتكس والذي قد يسبب حساسية شديدة.</p><p dir="RTL">كما هو الحال مع اللقاحات الأخرى، قد لا يؤدي فاكتا الأطفال إلى الحماية التامة لدى جميع من يتلقونه.</p><p dir="RTL">یرجی إخبار طبیبك إذا کان لدیك أو لدى لطفلك تاریخ من الإصابة باليرقان أو سبق لأي منكما العيش في منطقة یعتبر &nbsp;فيها&nbsp; التهاب الكبد الوبائي أ شائعًا. سوف یحدد طبیبك إذا کان ینبغي فحص الأجسام المضادة لالتهاب الكبد الوبائي أ لديك أو لدى طفلك قبل التطعیم.</p><p dir="RTL"><br /><strong>أدوية أخرى و فاكتا الأطفال</strong><br />أخبر طبيبك أو الصيدلي إذا كنت تتناول أنت أو طفلك ، قد تناولت مؤخرًا أو قد تتناول أي أدوية أخرى (أو لقاحات الأخرى).</p><p dir="RTL">يمكن إعطاء هذا اللقاح في نفس الوقت الذي يتم فيه إعطاء أي من اللقاحات التالية بشرط إعطاءها في أجزاء مختلفة من الجسم (على سبيل المثال ذراع أو ساق آخر) ولا يتم خلطها في نفس الحقنة.<br />&nbsp; &bull; لقاحات الحصبة والنكاف والحصبة الألمانية وفاريسيلا (جدري الماء)،<br />&nbsp; &bull; لقاح المكورات الرئوية السباعي التكافؤ المٌتحد،<br />&nbsp; &bull; لقاح شلل الأطفال (المعطل)<br />&nbsp; &bull; ذوفان الخناق &quot;توكسويد الدفتيريا&quot;، وذوفان الكزاز، والسعال الديكي اللاخلوي، والقاحات المستدمية النزلية &nbsp;ب &quot;هيموفيلاس انفلونزا ب&quot;،<br />&nbsp; &bull; الغلوبولين المناعي (الأجسام المضادة التي تم الحصول عليها من المتبرعين بالدم)</p><p dir="RTL">لدى البالغين، يمكن إعطاء فاكتا في نفس الوقت مع لقاح الحمى الصفراء ولقاح التيفوئيد متعدد السكّريات.</p><p dir="RTL"><strong>الحمل، الرضاعة الطبيعية والخصوبة</strong><br />إذا كنتِ أنتِ أو طفلتُكِ حاملًا أو مرضعة، أو تعتقدين أنكِ قد تكونين حاملًا أنت أو طفلتُكِ أو تُخططين لإنجاب طفل، استشيري طبيبك أو الصيدلي لتتحققي إذا كان ينبغي أن تتلقين اللقاح أنتِ أو طفلتُكِ.</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">لا توجد بيانات تشير إلى أن فاكتا الأطفال يؤثر على القدرة على القيادة أو تشغيل الآلات.</p><p dir="RTL"><strong>فاكتا الأطفال يحتوي على الصوديوم</strong></p><p dir="RTL">فاكتا الأطفال يحتوي على أقل من 1 مليمول من الصوديوم (23 ملغم) في كل جرعة، أي أساسا &quot;خالية من الصوديوم&quot;.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">سيتم حقن اللقاح من قبل طبيب أو ممرض تم تدريبه على استخدام اللقاحات وعلى التعامل مع أي رد فعل تحسسي شديد نادر قد ينجم عن الحقن.</p><p dir="RTL">وتتحقق الحماية على المدى القصير ضد التهاب الكبد الوبائي&nbsp; أ &nbsp;في غضون 2-4 أسابيع بعد تلقي هذا المطعوم.</p><p dir="RTL">وتتطلب الحماية على المدى الطويل ضد التهاب الكبد الوبائي أ &nbsp;حقن جرعة ثانية (معززة) من لقاح التهاب الكبد الوبائي أ &nbsp;المُعطّل. وعادة تُعطى الجرعة الثانية بين 6 و 18 شهرًا بعد الجرعة الأولى. وقد وُجد أن الأطفال الأصحاء الذين تلقوا جرعتين من اللقاح استمرت لديهم الأجسام المضادة لمدة 10 سنوات على الأقل. ومن المتوقع أن تبقى الأجسام المضادة لالتهاب الكبد الوبائي أ &nbsp;في الجسم على الأقل 25 عاما بعد التطعيم.</p><p dir="RTL">لم يتم إثبات السلامة والفعالية لدى الرضّع أقل من 12 شهرا من العمر.</p><p dir="RTL"><strong>طريقة الإعطاء </strong></p><p dir="RTL">سوف يرجّ الطبيب أو الممرض الحقنة مباشرة قبل الاستخدام ويتحقق من أن السائل أبيض ومُعتم وأنه لا يحتوي على جزيئات كبيرة.</p><p dir="RTL">يعطى اللقاح كحقنة في العضل في الجزء الخارجي العلوي من الذراع (العضلة الدّاليّة). يمكن استخدام العضلات في منطقة الفخذ الخارجي للحقن عند الأطفال إذا لم تكن العضلات الدّاليّة متطورة بشكل كافٍ. سيتجنّب طبيبك أو ممرضك إعطاءك أنت أو طفلك الحقنة في الجلد أو في وعاء دموي. قد يتم تطعيم الأطفال ممن هم عرضة لخطر حدوث نزيف كثير بعد الحقن (انظر الفقرة رقم 2) في بعض الأحيان بإعطاء فاكتا الأطفال كحقنة تحت الجلد ولكن ليس في العضل في محاولة للحد من خطر النزيف.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كما هو الحال مع سائر الأدوية واللقاحات ، يمكن أن يسبب هذا اللقاح أعراضًا جانبية، وإن كانت لا تحدث لدى جميع من يتلقوه.</p><p dir="RTL">كما هو الحال مع جميع اللقاحات، قد تحدث ردود فعل تحسسية، والتي قد تؤدي في حالات نادرة إلى الصدمة. وقد تشمل هذه التفاعلات ما يلي:<br />- الشرى<br />- صعوبة في التنفس<br />- تورم في الوجه واللسان والحلق<br />- الدوخة<br />- الانهيار</p><p dir="RTL">عندما تحدث هذه العلامات أو الأعراض فإنها عادة تتطور بسرعة كبيرة بعد إعطاء الحقنة وغالبًا أثناء وجودك أنت أو طفلك في عيادة التطعيم أو الجراحة. <strong>إذا حدث أيّ من هذه الأعراض بعد مغادرة المكان الذي تلقيت فيه الحقنة أنت أو طفلك، اتصل بالطبيب فورا.</strong></p><p dir="RTL">الأعراض الجانبية المُبَلّغ عنها لدى الأطفال الذين تتراوح أعمارهم بين 12 شهرا إلى 23 شهرا</p><table dir="rtl" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><strong>تكرار حدوث الأعراض الجانبية</strong></p></td><td style="vertical-align:top"><p dir="RTL"><strong>الأعراض الجانبية</strong></p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">شائعة جدا: قد تؤثر على أكثر من 1 من بين 10 أطفال</p></td><td style="vertical-align:top"><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم/ إيلام (ألم عند اللمس) واحمرار في موضع الحقن.</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">شائعة: قد تؤثر على ما يصل إلى 1 من بين 10 أطفال</p></td><td style="vertical-align:top"><p dir="RTL">- تورم ودفء وظهور كدمات في موضع الحقن</p><p dir="RTL">- حمى<br />- هيجان<br />- إسهال</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">غير شائعة: قد تؤثر على ما يصل إلى 1 من بين 100 طفل</p></td><td style="vertical-align:top"><p dir="RTL">- انخفاض أو فقدان الشهية</p><p dir="RTL">- صعوبة في النوم، والنعاس، والشعور بالتعب - النعاس، أو نقص<br />&nbsp;&nbsp; الطاقة، والتململ</p><p dir="RTL">- البكاء</p><p dir="RTL">- سيلان الأنف، والسعال، واحتقان الأنف</p><p dir="RTL">- التقيؤ</p><p dir="RTL">- طفح جلدي، طفح الحفاضات</p><p dir="RTL">- الشعور بالتوعك</p><p dir="RTL">- نتوء وطفح جلدي في موضع الحقن</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">نادرة: قد تؤثر على ما يصل إلى 1 من بين 1000 طفل</p></td><td style="vertical-align:top"><p dir="RTL">- حساسية متعددة</p><p dir="RTL">- جفاف</p><p dir="RTL">- الإثارة، والعصبية، والخوف، والصراخ</p><p dir="RTL">- الدوخة، والصداع، وفقدان التوازن</p><p dir="RTL">- ظهور قشرة علة حافة الجفن</p><p dir="RTL">- الربو، انسداد مجرى التنفس، العطاس، سيلان أو حكة الأنف، ألم<br />&nbsp;&nbsp; في الفم والحلق.</p><p dir="RTL">- الغثيان، ألم في المعدة/عدم الراحة، الغاز المفرط في المعدة أو<br />&nbsp;&nbsp; الأمعاء، وحركات الأمعاء المتكررة، والتجشؤ، البصق الطفولي،<br />&nbsp;&nbsp; والإمساك، تغير لون البراز</p><p dir="RTL">- طفح جلدي، حكة واحمرار في الجلد، بثور، دفء أو تندّي الجلد<br />&nbsp;&nbsp; بالعرق &nbsp;<br />- المفاصل الملتهبة</p><p dir="RTL">- في موضع الحقن: نزيف، حكة، تلون، نتوء أو طفح<br />&nbsp;&nbsp; مصحوب بحكة؛ الألم، عدم الراحة</p><p dir="RTL">- التعب، واختلال في طريقة المشي، والشعور بالحرارة</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">غير معروف: لا يمكن تقدير تكرار الحدوث من البيانات المتاحة</p></td><td style="vertical-align:top"><p dir="RTL">- متلازمة غيلان باريه (ضعف العضلات، والأحاسيس الشاذة،<br />&nbsp;&nbsp; وخز في الذراعين والساقين والجزء العلوي من الجسم)</p><p dir="RTL">- نقص الصفيحات (انخفاض عدد الصفائح الدموية مما يزيد من<br />&nbsp;&nbsp; مخاطر النزيف والكدمات</p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL">الأعراض الجانبية المُبلّغ عنها لدى الأطفال الذين تتراوح أعمارهم بين 2 إلى 17 عاما</p><table dir="rtl" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><strong>تكرار حدوث الأعراض الجانبيّة</strong></p></td><td style="vertical-align:top"><p dir="RTL"><strong>الأعراض الجانبيّة</strong></p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">شائعة جدا: قد تؤثر على أكثر من 1 من بين 10 أطفال</p></td><td style="vertical-align:top"><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم / وإيلام (ألم عند اللمس) في موضع الحقن</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">شائعة: قد تؤثر على ما يصل إلى 1 من بين 10 أطفال</p></td><td style="vertical-align:top"><p dir="RTL">- صداع<br />- دفء، واحمرار وتورم موضع الحقن، والحمى، والنزيف تحت<br />&nbsp;&nbsp; الجلد في موقع الحقن (كدمات)</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">غير شائعة: قد تؤثر على ما يصل إلى 1 من بين 100 طفل</p></td><td style="vertical-align:top"><p dir="RTL">- الهيجان &nbsp;</p><p dir="RTL">- دوخة</p><p dir="RTL">- آلام في المعدة، والتقيؤ، والإسهال، والغثيان</p><p dir="RTL">- طفح جلدي، حكة</p><p dir="RTL">- ألم في الذراع (الذي حُقن فيه)، وآلام المفاصل، وآلام في<br />&nbsp;&nbsp; العضلات</p><p dir="RTL">- ضعف/تعب، وحكة في موضع الحقن والألم/وجع</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">نادرة: قد تؤثر على ما يصل إلى 1 من بين 1000 طفل</p></td><td style="vertical-align:top"><p dir="RTL">- فقدان الشهية<br />- العصبية</p><p dir="RTL">- النعاس، وأحاسيس غير طبيعية في الجلد مثل الوخز</p><p dir="RTL">- آلام الأذن</p><p dir="RTL">- احمرار الوجه</p><p dir="RTL">- سيلان أو انسداد الأنف، والسعال</p><p dir="RTL">- الشرى، والتعرق</p><p dir="RTL">- التيبُس</p><p dir="RTL">- صلابة (تصلب) في موقع الحقن، ومرض يشبه الانفلونزا، وألم<br />&nbsp;&nbsp; في الصدر، والألم، والدفء، وتكوّن قشرة، وتيبُس/ضيق ووخز<br />&nbsp;&nbsp; في موضع الحقن.</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">غير معروف: لا يمكن تقدير تكرار الحدوث من البيانات المتاحة</p></td><td style="vertical-align:top"><p dir="RTL">- متلازمة غيلان باريه (ضعف العضلات، والأحاسيس الشاذة،<br />&nbsp;&nbsp; وخز في الذراعين والساقين والجزء العلوي من الجسم)</p><p dir="RTL">- نقص الصفيحات (انخفاض عدد الصفائح الدموية مما يزيد من<br />&nbsp;&nbsp; مخاطر النزيف والكدمات)</p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&nbsp;الإبلاغ عن الأعراض الجانبية</strong><br />إذا تعرّضت لأي أعراض جانبية، تحدث مع طبيبك أو الصيدلي أو الممرض. ويشمل ذلك أي أعراض جانبية محتملة غير مدرجة في هذه النشرة. يمكنك أيضا الإبلاغ عن الأعراض الجانبية مباشرة عن طريق المركز الوطني للتيقظ والسلامة الدوائية، التابع لهيئة العامة للغذاء والدواء &ndash; المملكة العربية السعودية. وبالإبلاغ عن الأعراض الجانبية يمكنك المساعدة في توفير مزيد من المعلومات حول سلامة هذا الدواء.</p><p dir="RTL">بالإبلاغ عن الأعراض الجانبية يمكنك المساعدة في توفير مزيد من المعلومات حول سلامة هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><!--[if !supportLists]--></p><p dir="RTL">يُحفظ هذا اللقاح بعيدًا عن مرأى ومتناول الأطفال.</p><p dir="RTL">یجب عدم استخدام اللقاح بعد تاریخ&nbsp; انتهاء الصلاحیة (EXP) الذي&nbsp; يظهر علی العلبة من الخارج وملصق&nbsp; الحقنة.</p><p dir="RTL">يجب أن يتم تخزين اللقاح في الثلاجة بين 2 - 8 درجة مئوية (للتأكد من أنه لا يتجمّد) بحيث يحتفظ اللقاح بفعاليته.</p><p dir="RTL">لا تستخدم هذا اللقاح إذا لاحظت أن لديه مظهر غير عادي (انظر الفقرة رقم 6) أو يحتوي على الجسيمات.</p><p dir="RTL">لا تتخلص من أي أدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد تستخدمها. وستساعد هذه التدابير على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">العنصر النشط هو: فيروس التهاب الكبد الوبائي أ &nbsp;غير الفعال (الذي يتم إنتاجه على الخلايا البشرية المُضاعفة إم أر سي 5 مُمتزّ على كبريتات هيدروكسي فوسفات الألمنيوم غير المتبلور).</p><p dir="RTL">تحتوي كل جرعة واحدة (0.5 ملل) على 25 وحدة من فيروس التهاب الكبد الوبائي&nbsp; أ &nbsp;(غير الفعال) امتُزّت على كبريتات هيدروكسي فوسفات الألمنيوم غير المتبلور (0.225 ملليجرام من الألومنيوم).</p><p dir="RTL">المكونات الأخرى هي:</p><p dir="RTL">&bull; بورات الصوديوم ديكاهيدرات (035&sbquo; 0 ملغم/جرعة)<br />&bull; كلوريد الصوديوم (4.5 ملغم)<br />&bull; الماء المُخصّص للحقن (الكمية الكافية)</p><p><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يتوفر لقاح فاكتا على شكل حقن &nbsp;مسبقة التعبئة أو فيال تحتوي على 0.5 ملليلتر (جرعة واحدة) من اللقاح. علبة اللقاح تحتوي عبوة واحدة من الفيال أو الحقنة مسبقة التعبئة مع أو بدون إبرة.</p><p dir="RTL">قد لا تُسوق جميع أنواع العبوات.</p><p dir="RTL">يظهر لقاح فاكتا بعد الرجّ الجيد على شكل مُعلّق أبيض معتم.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>الشركة المالكة لحقوق التسويق :</strong><br />ميرك شارب و دوهم بي في ،<br />وارديرويج 39، 2031 بي ان هارلم<br />هولندا</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الشركة المُصَنّعة:</strong><br />شركة ميرك، شارب ودوهم ذ م م،<br />سومنيتون بايك، صندوق بريد 4، ويست بوينت، بي إيه ،الولايات المتحدة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            
تمت الموافقة على هذه النشرة بتاريخ { ديسمبر 2020}

للإبلاغ عن الأعراض الجانبية:
•	المملكة العربية السعودية:
المركز الوطني للتيقظ والسلامة الدوائية
للاتصال باالهيئة العامة للغذاء والدواء: 1999
البريد الالكتروني: npc.drug@sfda.gov.sa
الموقع الالكتروني: https://ade.sfda.gov.sa
•	دول الخليج الأخرى
الرجاء الاتصال بالمؤسسات والهيئات الوطنية في كل دولة.

(إنّ هذا الدواء)
- الدواء مستحضر يؤثر على صحتك واستهلاكه خلافًا للتعليمات يعرضك للخطر
- اتبع بدقة وصفة الطبيب وطريقة الاستعمال المنصوص عليها وتعليمات الصيدلاني الذي صرفها لك
- إن الطبيب والصيدلاني هما الخبيران بالدواء وبنفعه وضرره
- لا تقطع مدة العلاج المحددة لك من تلقاء نفسك
- لا تكرر صرف الدواء بدون استشارة الطبيب
- لا تترك الأدوية في متناول أيدي الأطفال
مجلس وزراء الصحة العرب
و اتحاد الصيادلة العرب
تمت الموافقة على نشرة المعلومات الخاصة بالمريض من قبل الهيئة العامة للغذاء والدواء السعودية



المعلومات التالية مُوجهة لأخصائيي الرعاية الصحية فقط:

عدم التوافق
يجب عدم خلط هذا المنتج الطبي مع المنتجات الطبية الأخرى لأنّه لا تتوفر دراسات عن التوافق مع المنتجات الطبيّة الأخرى.
تعليمات الاستخدام 
يجب استخدام اللقاح كما هو بدون أي تغيير.
وينبغي فحص اللقاح بصريا قبل إعطاء اللقاح تحسّبا لوجود أي جسيمات غريبة و/أو مظهر غير طبيعي. تخلّص من المنتج إذا لاحظت وجود جسيمات أو تغير في اللون. يجب رجّ المِحقنة بشكل جيد حتى يتم الحصول على مُعلّق أبيض غميم قليلا.
الرجّ الشامل ضروري للحفاظ على اللقاح بشكل مُعلّق. ولوصل الإبرة بالمِحقنة التي تتوفر بدون إبرة متصلة بها، امسك بالمحقنة من الجزء الاسطواني ثم صِل الإبرة بها وقم بلفّ الإبرة في اتجاه عقارب الساعة حتى تثبت في مكانها على المِحقنة بشكل آمن وقم بإعطاء اللقاح على الفور.

        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                VAQTA® Paediatric, suspension for injection
Hepatitis A Vaccine, inactivated, adsorbed. For children and adolescents.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                One dose (0.5 mL) contains:
Hepatitis A virus (strain CR 326F) (inactivated) 1,2	25 U3
1 Produced on human diploid (MRC–5) fibroblast cells.
2 Adsorbed on amorphous aluminium hydroxyphosphate sulfate (0.225 mg Al3+).
3 Units measured according to the in-house method of the manufacturer-Merck Sharp & Dohme Corp.

This vaccine may contain traces of neomycin and formaldehyde, which are used during the manufacturing process. See sections 4.3 and 4.4.

For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Suspension for injection in a prefilled syringe.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>VAQTA Paediatric is indicated for active pre-exposure prophylaxis against disease caused by hepatitis A virus. VAQTA Paediatric is recommended for healthy individuals from 12 months of age to 17 years of age who are at risk of contracting or spreading infection or who are at risk of life-threatening disease if infected (e.g., hepatitis C with diagnosed liver disease).</p><p>&nbsp;</p><p>The use of VAQTA Paediatric should be based on official recommendations.</p><p>&nbsp;</p><p>For optimal antibody response, primary immunisation should be given at least 2, preferably 4, weeks prior to expected exposure to hepatitis A virus.</p><p>&nbsp;</p><p>VAQTA Paediatric will not prevent hepatitis caused by infectious agents other than hepatitis A virus.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Posology</em></p><p><em>&nbsp;</em></p><p>The vaccination series consists of one primary dose and one booster dose given according to the following schedule:</p><p>&nbsp;</p><p><em>Primary dose:</em></p><p><em>&nbsp;</em></p><p>Children and adolescents aged 12 months to 17 years of age should receive a single 0.5 mL (25 U) dose of vaccine at an elected date.</p><p>&nbsp;</p><p>Safety and effectiveness in infants &lt;12 months of age have not been established.</p><p>&nbsp;</p><p><em>Booster dose:</em></p><p><em>&nbsp;</em></p><p>Individuals who received a primary dose at 12 months to 17 years of age should receive a booster dose of 0.5 mL (25 U) 6 to 18 months after the first dose.</p><p>&nbsp;</p><p>Hepatitis A virus (HAV) antibodies persist for at least 10 years after the second dose (i.e. booster). Based on mathematic modeling duration of antibody persistence is predicted for at least 25 years (see section 5.1).</p><p>&nbsp;</p><p><em>Interchangeability of the booster dose</em></p><p>A booster dose of VAQTA Paediatric may be given at 6 to 12 months following the initial dose of other inactivated hepatitis A vaccines as shown by data for adults, 18 to 83 years of age; no such data are available for VAQTA (25 U/0.5 mL) presentation.</p><p>&nbsp;</p><p><em>Method of administration</em></p><p><em>&nbsp;</em></p><p>VAQTA Paediatric should be injected INTRAMUSCULARLY. The deltoid muscle is the preferred site for injection. The anterolateral thigh region may be used in infants if the deltoid muscle is not sufficiently developed. The vaccine should not be administered subcutaneously or intradermally since administration by these routes may result in a less than optimal antibody response.</p><p>&nbsp;</p><p>For individuals with bleeding disorders who are at risk of haemorrhage following intramuscular injection (e.g., haemophiliacs) other measures can be taken such as intramuscular administration of the vaccine after anti- haemophilia or other similar therapy, or applying pressure. This vaccine may be administered subcutaneously to these subjects.</p><p>&nbsp;</p><p><em>Precautions to be taken before handling or administering the medicinal product </em>For instructions on preparation of the medicinal product before administration, see section 6.6.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                History of hypersensitivity to the active substances, to any of the excipients listed in section 6.1, to neomycin or to formaldehyde (which may be present as trace residues, see sections 2 and 4.4).

Vaccination should be delayed in subjects with current severe febrile infections.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Traceability</u></p><p>In order to improve the traceability of biological medicinal products, the name and the batch number of the administered product should be clearly recorded.</p><p>&nbsp;</p><p>Individuals who develop symptoms suggestive of hypersensitivity after an injection of VAQTA Paediatric should not receive further injections of the vaccine. This vaccine may contain traces of neomycin and formaldehyde which are used during the manufacturing process (see sections 2 and 4.3).</p><p>&nbsp;</p><p>VAQTA Paediatric must not be administered into a blood vessel.</p><p>&nbsp;</p><p>Use caution when vaccinating latex-sensitive individuals since the syringe plunger stopper and tip cap contain dry natural latex rubber that may cause allergic reactions.</p><p>&nbsp;</p><p>Qualitative testing for antibodies to hepatitis A prior to immunisation should be considered based on the probability of previous hepatitis A virus infection in patients who grew up in areas of high endemicity, and/or with a history of jaundice.</p><p>&nbsp;</p><p>VAQTA Paediatric does not cause immediate protection against hepatitis A, and there may be a period of 2 to 4 weeks before antibody becomes detectable.</p><p>&nbsp;</p><p>VAQTA Paediatric will not prevent hepatitis caused by infectious agents other than hepatitis A virus. Because of the long incubation period (approximately 20 to 50 days) for hepatitis A, it is possible for unrecognised hepatitis A infection to be present at the time the vaccine is given. The vaccine may not prevent hepatitis A in such individuals.</p><p>&nbsp;</p><p>As with any vaccine, adequate treatment provisions, including epinephrine (adrenaline), should be available for immediate use should an anaphylactic or anaphylactoid reaction occur.</p><p>&nbsp;</p><p>As with any vaccine, vaccination with VAQTA Paediatric may not result in a protective response in all susceptible vaccinees.</p><p>&nbsp;</p><p>Excipient(s) with known effect:</p><p>This medicinal product contains less than 1mmol (23mg) sodium per dose and is considered to be essentially sodium free.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>If VAQTA Paediatric is used in individuals with malignancies or those receiving immunosuppressive therapy or who are otherwise immunocompromised, the expected immune response may not be obtained.</p><p><em>Known or presumed exposure to HAV/Travel to endemic areas Use with immune globulin</em></p><p>For individuals requiring either post-exposure prophylaxis or combined immediate and longer term protection (e.g., travelers departing on short notice to endemic areas), in countries where IG is available VAQTA Paediatric may be administered concomitantly with IG using separate sites and syringes. Although the antibody titre obtained is likely to be lower than when the vaccine is given alone. The clinical relevance of this observation has not been established.</p><p>&nbsp;</p><p><em>Use with other vaccines</em></p><p>Hepatitis A response has been shown to be similar when VAQTA Paediatric was given alone or concomitantly with measles, mumps, rubella, varicella, pneumococcal 7-valent conjugate, inactivated polio, diphtheria toxoid, tetanus toxoid, acellular pertussis, or <em>Haemophilus influenzae </em>b vaccine. Responses to measles, mumps, rubella, varicella, pneumococcal 7-valent conjugate, inactivated polio, diphtheria toxoid, tetanus toxoid, acellular pertussis, and <em>Haemophilus influenzae </em>b vaccine were not affected by concomitant administration with VAQTA Paediatric. Studies in adults 18 to 54 years of age have shown that VAQTA may be administered concomitantly with yellow fever and polysaccharide typhoid vaccines.</p><p>&nbsp;</p><p>VAQTA Paediatric must not be mixed with other vaccines in the same syringe. When concurrent administration is necessary, different injection sites and separate syringes must be used for each vaccine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p>It is not known whether VAQTA Paediatric can cause foetal harm when administered to a pregnant woman or can affect reproduction capacity. VAQTA Paediatric is not recommended in pregnancy unless there is a high risk of hepatitis A infection, and the attending physician judges that the possible benefits of vaccination outweigh the risks to the foetus.</p><p>&nbsp;</p><p><u>Breast-feeding</u></p><p>It is not known whether VAQTA Paediatric is excreted in human milk, and the effect on breastfed infants following administration of VAQTA Paediatric to mothers has not been studied. Hence, VAQTA Paediatric should be used with caution in women who are breastfeeding.</p><p>&nbsp;</p><p><u>Fertility</u></p><p>VAQTA Paediatric has not been evaluated in fertility studies.</p><p>&nbsp;</p><p>Animal reproduction studies have not been conducted with VAQTA Paediatric.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No studies on the effects on the ability to drive and use machines have been performed. However, VAQTA Paediatric is expected to have no or negligible influence on the ability to drive and use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><!--[if !supportLists]--></p><p>4.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Summary of the safety profile</p><p><em>Children 12 months through 23 months of age</em></p><p>In 5 combined clinical trials, 4,374 children 12 through 23 months of age received one or two 25 U doses of VAQTA Paediatric. Out of the 4,374 children who received VAQTA Paediatric, 3,885 (88.8%) children received 2 doses of VAQTA Paediatric and 1,250 (28.6%) children received VAQTA Paediatric concomitantly with other vaccines. Children were followed for elevated temperature and injection-site adverse reactions during a 5-day period postvaccination and systemic adverse events including fever during a 14-day period postvaccination.</p><p>&nbsp;</p><p>In three of the five protocols which specifically prompted for injection-site erythema, pain/tenderness, and swelling daily for Day 1 through Day 5 postvaccination, the most frequently reported injection-site adverse reaction after any dose of VAQTA Paediatric was injection-site pain/tenderness.</p><p>&nbsp;</p><p>The most common systemic adverse events among recipients of VAQTA Paediatric alone were fever and irritability. The data from the five protocols were combined as similar methods for collecting systemic adverse events were used.</p><p>&nbsp;</p><p><em>Children/adolescents (2 years through 17 years of age)</em></p><p>In clinical trials with 2,595 healthy children (22 years of age) and adolescents who received one or more doses of hepatitis A vaccine, subjects were followed for elevated temperature and local reactions during a 5-day period postvaccination and systemic adverse events including fever during a 14-day period postvaccination. Injection-site reactions, generally mild and transient, were the most frequently reported adverse events.</p><p>Adverse reactions reported as vaccine related are listed below in decreasing order of frequency within each system organ classification.</p><p>&nbsp;</p><p><em>Post-marketing Safety Study</em></p><p>In a post-marketing safety study, a total of 12,523 individuals 2 through 17 years of age received 1 or 2 doses of VAQTA Paediatric. There was no serious, vaccine-related, adverse event identified. There was no non-serious, vaccine-related, adverse event resulting in outpatient visits.</p><p>&nbsp;</p><p>Tabulated summary of adverse reactions</p><p><strong>&nbsp;</strong></p><p>The tables below present adverse reactions reported as vaccine related observed in clinical trials, and in a post-authorisation safety study and adverse reactions spontaneously reported after use of the marketed vaccine.</p><p>&nbsp;</p><p>Adverse reactions are ranked under headings of frequency using the following convention:</p><p>&nbsp;</p><p><!--[if gte vml 1]><v:shapetype
 id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t"
 path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="image1.png" o:spid="_x0000_s1031" type="#_x0000_t75"
 style='position:absolute;left:0;text-align:left;margin-left:206.15pt;
 margin-top:3.3pt;width:6.35pt;height:7pt;z-index:-16149504;visibility:visible;
 mso-wrap-style:square;mso-wrap-distance-left:0;mso-wrap-distance-top:0;
 mso-wrap-distance-right:0;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:page;
 mso-position-vertical:absolute;mso-position-vertical-relative:text'>
 <v:imagedata src="file:///C:/Users/alsirhan/AppData/Local/Temp/msohtmlclip1/01/clip_image001.png"
  o:title=""/>
 <w:wrap anchorx="page"/>
</v:shape><![endif]--><img width="9" height="9" src="file:///C:/Users/alsirhan/AppData/Local/Temp/msohtmlclip1/01/clip_image002.gif" /><!--[if gte vml 1]><v:shape id="_x0000_s1030"
 type="#_x0000_t75" style='position:absolute;left:0;text-align:left;
 margin-left:300.3pt;margin-top:3.3pt;width:6.35pt;height:7pt;z-index:-16148992;
 visibility:visible;mso-wrap-style:square;mso-wrap-distance-left:0;
 mso-wrap-distance-top:0;mso-wrap-distance-right:0;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:page;
 mso-position-vertical:absolute;mso-position-vertical-relative:text'>
 <v:imagedata src="file:///C:/Users/alsirhan/AppData/Local/Temp/msohtmlclip1/01/clip_image001.png"
  o:title=""/>
 <w:wrap anchorx="page"/>
</v:shape><![endif]--><img width="9" height="9" src="file:///C:/Users/alsirhan/AppData/Local/Temp/msohtmlclip1/01/clip_image002.gif" /><!--[if gte vml 1]><v:shape id="image2.png"
 o:spid="_x0000_s1029" type="#_x0000_t75" style='position:absolute;left:0;
 text-align:left;margin-left:460.25pt;margin-top:3.3pt;width:6.35pt;height:7pt;
 z-index:-16148480;visibility:visible;mso-wrap-style:square;
 mso-wrap-distance-left:0;mso-wrap-distance-top:0;mso-wrap-distance-right:0;
 mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:page;mso-position-vertical:absolute;
 mso-position-vertical-relative:text'>
 <v:imagedata src="file:///C:/Users/alsirhan/AppData/Local/Temp/msohtmlclip1/01/clip_image003.png"
  o:title=""/>
 <w:wrap anchorx="page"/>
</v:shape><![endif]--><img width="9" height="9" src="file:///C:/Users/alsirhan/AppData/Local/Temp/msohtmlclip1/01/clip_image004.gif" /><em>[Very Common ( 1/10); Common ( 1/100 to &lt;1/10); Uncommon ( 1/1,000 to</em></p><p><!--[if gte vml 1]><v:shape id="image3.png" o:spid="_x0000_s1028" type="#_x0000_t75"
 style='position:absolute;left:0;text-align:left;margin-left:203.1pt;
 margin-top:4.55pt;width:6.35pt;height:7pt;z-index:-16147968;visibility:visible;
 mso-wrap-style:square;mso-wrap-distance-left:0;mso-wrap-distance-top:0;
 mso-wrap-distance-right:0;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:page;
 mso-position-vertical:absolute;mso-position-vertical-relative:text'>
 <v:imagedata src="file:///C:/Users/alsirhan/AppData/Local/Temp/msohtmlclip1/01/clip_image005.png"
  o:title=""/>
 <w:wrap anchorx="page"/>
</v:shape><![endif]--><img width="9" height="9" src="file:///C:/Users/alsirhan/AppData/Local/Temp/msohtmlclip1/01/clip_image006.gif" /><em>&lt;1/100); Rare ( 1/10,000 to &lt;1/1,000); Very Rare (&lt;1/10,000); Not Known (cannot be estimated from the available data)].</em></p><p><em>&nbsp;</em></p><p><em>Children 12 months through 23 months of age</em></p><p><em>&nbsp;</em></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Class</strong></p></td><td style="vertical-align:top"><p><strong>Frequency</strong></p></td><td style="vertical-align:top"><p><strong>Adverse Reactions</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Blood and lymphatic system</em></p><p><em>disorders</em></p></td><td style="vertical-align:top"><p>Not Known</p></td><td style="vertical-align:top"><p>Thrombocytopenia<sup>1</sup></p></td></tr><tr><td style="vertical-align:top"><p><em>Immune system</em></p><p><em>disorders</em></p></td><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Multiple allergies</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><em>Metabolism and nutrition disorders</em></p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Decreased appetite, Anorexia</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Dehydration</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><em>Psychiatric disorders</em></p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Insomnia, Restlessness</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Agitation, Nervousness,</p><p>Phobia, Screaming, Sleep disorder</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p><em>Nervous system disorders</em></p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Somnolence, Crying, Lethargy, Hypersomnia,</p><p>Poor quality sleep</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Dizziness, Headache, Ataxia</p></td></tr><tr><td style="vertical-align:top"><p>Not Known</p></td><td style="vertical-align:top"><p>Guillain-Barr&eacute; syndrome<sup>1</sup></p></td></tr><tr><td style="vertical-align:top"><p><em>Eye disorders</em></p></td><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Eyelid margin crusting</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><em>Respiratory, thoracic and mediastinal disorders</em></p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Rhinorrhea, Cough, Nasal congestion</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Respiratory tract congestion, Sneezing, Asthma, Allergic rhinitis,</p><p>Oropharyngeal pain</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p><em>Gastrointestinal disorders</em></p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Diarrhoea</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Vomiting</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Flatulence, Abdominal distension, Upper abdominal pain, Faeces</p><p>discolored, Frequent</p></td></tr></tbody></table><p>&nbsp;</p><p><em>&nbsp;</em></p><p><em>&nbsp;</em></p><p><!--[if gte vml 1]><v:shapetype
 id="_x0000_t202" coordsize="21600,21600" o:spt="202" path="m,l,21600r21600,l21600,xe">
 <v:stroke joinstyle="miter"/>
 <v:path gradientshapeok="t" o:connecttype="rect"/>
</v:shapetype><v:shape id="Text_x0020_Box_x0020_13" o:spid="_x0000_s1027"
 type="#_x0000_t202" style='position:absolute;left:0;text-align:left;
 margin-left:88.4pt;margin-top:-464.75pt;width:451.15pt;height:471.75pt;
 z-index:487170560;visibility:visible;mso-wrap-style:square;
 mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:9pt;
 mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
 mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:page;mso-position-vertical:absolute;
 mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0;
 mso-width-relative:page;mso-height-relative:page;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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" filled="f" stroked="f">
 <v:textbox inset="0,0,0,0"/>
 <w:wrap anchorx="page"/>
</v:shape><![endif]--></p><table cellpadding="0" cellspacing="0"><tbody><tr><td><table cellpadding="0" cellspacing="0" style="width:100%"><tbody><tr><td><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>bowel movements, Nausea, Stomach discomfort, Constipation, Eructation, Infantile</p><p>spitting up</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><em>Skin and subcutaneous tissue disorders</em></p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Rash, Dermatitis diaper</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Urticaria, Cold sweat, Eczema, Generalized erythema, Papular rash, Blister, Erythema, Generalized rash, Heat rash, Hyperhidrosis, Skin</p><p>warm</p></td></tr><tr><td style="vertical-align:top"><p><em>Musculoskeletal, connective tissue disorders</em></p></td><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Synovitis</p></td></tr><tr><td rowspan="4" style="vertical-align:top"><p><em>General disorders and administrative site conditions</em></p></td><td style="vertical-align:top"><p>Very Common</p></td><td style="vertical-align:top"><p>Injection-site pain/ tenderness, Injection-site</p><p>erythema</p></td></tr><tr><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Injection-site swelling, Fever, Irritability, Injection-site warmth,</p><p>Injection-site bruising</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Injection-site hematoma, Injection-site nodule, Malaise, Injection-site</p><p>rash,</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Pain, Injection-site haemorrhage, Injection- site pruritus, Discomfort, Fatigue, Gait disturbance, Injection- site discoloration, Injection-site papule, Injection-site urticaria,</p><p>Feeling hot</p></td></tr></tbody></table><p>&nbsp;</p></td></tr></tbody></table></td></tr></tbody></table><p><sup>1</sup> Spontaneous reporting after use of marketed vaccine</p><p>&nbsp;</p><p><em>Children/adolescents (2 years through 17 years of age)</em></p><p><em>&nbsp;</em></p><p><em>&nbsp;</em></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Class</strong></p></td><td style="vertical-align:top"><p><strong>Frequency</strong></p></td><td style="vertical-align:top"><p><strong>Adverse Events</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Blood and lymphatic system</em></p><p><em>disorders</em></p></td><td style="vertical-align:top"><p>Not Known</p></td><td style="vertical-align:top"><p>Thrombocytopenia<sup>1</sup></p></td></tr><tr><td style="vertical-align:top"><p><em>Metabolism and nutrition disorders</em></p></td><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Anorexia</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><em>Psychiatric</em></p><p><em>disorders</em></p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Irritability</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Nervousness</p></td></tr></tbody></table><p><em>&nbsp;</em></p><p><!--[if gte vml 1]><v:shape
 id="Text_x0020_Box_x0020_12" o:spid="_x0000_s1026" type="#_x0000_t202"
 style='position:absolute;left:0;text-align:left;margin-left:79.4pt;
 margin-top:-475.85pt;width:453.35pt;height:475.7pt;z-index:487171584;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:page;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:page;
 mso-height-relative:page;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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==
" filled="f" stroked="f">
 <v:textbox inset="0,0,0,0"/>
 <w:wrap anchorx="page"/>
</v:shape><![endif]--></p><table cellpadding="0" cellspacing="0"><tbody><tr><td><table cellpadding="0" cellspacing="0" style="width:100%"><tbody><tr><td><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td rowspan="4" style="vertical-align:top"><p><em>Nervous system disorders</em></p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Headache</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Dizziness</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Somnolence, Paraesthesia</p></td></tr><tr><td style="vertical-align:top"><p>Not Known</p></td><td style="vertical-align:top"><p>Guillain-Barr&eacute; syndrome<sup>1</sup></p></td></tr><tr><td style="vertical-align:top"><p><em>Ear and labyrinth disorders</em></p></td><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Ear pain</p></td></tr><tr><td style="vertical-align:top"><p><em>Vascular disorders</em></p></td><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Flushing</p></td></tr><tr><td style="vertical-align:top"><p><em>Respiratory, thoracic and mediastinal</em></p><p><em>disorders</em></p></td><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Nasal congestion, Cough; Rhinorrhea</p></td></tr><tr><td style="vertical-align:top"><p><em>Gastrointestinal disorders</em></p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Abdominal pain, Vomiting, Diarrhoea, Nausea</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><em>Skin and subcutaneous</em></p><p><em>tissue disorders</em></p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Rash, Pruritus</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Urticaria, Sweating</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><em>Musculoskeletal,</em></p><p><em>connective tissue disorders</em></p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Arm pain (in the injected limb), Arthralgia, Myalgia</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Stiffness</p></td></tr><tr><td rowspan="4" style="vertical-align:top"><p><em>General disorders and administrative site conditions</em></p></td><td style="vertical-align:top"><p>Very Common</p></td><td style="vertical-align:top"><p>Injection-site pain and Tenderness</p></td></tr><tr><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Injection-site warmth, Erythema and Swelling, Fever, Injection-site</p><p>ecchymosis</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Asthenia/ fatigue, Injection-site pruritus and</p><p>Pain/ soreness</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Injection-site induration, Flu-like illness, Chest pain, Pain, Warm sensation, Injection-site scab, Stiffness/ tightness</p><p>and Stinging</p></td></tr></tbody></table><p>&nbsp;</p></td></tr></tbody></table></td></tr></tbody></table><p><sup>1</sup> Spontaneous reporting after use of marketed vaccine</p><p>&nbsp;</p><p><em>&nbsp;</em></p><p>&nbsp;</p><p>Description of selected adverse reactions</p><p>As with all vaccines, allergic reactions, in rare cases leading to shock, may occur (see section 4.4).</p><p>&nbsp;</p><p>Reporting of suspected adverse reactions</p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via:</p><p><strong>&nbsp;</strong></p><p><strong>To report any side effect(s):</strong></p><p>&middot; <u>Saudi Arabia: </u></p><p>The National Pharmacovigilance Centre (NPC):</p><p>SFDA Call Center: 19999</p><p>E-mail: npc.drug@sfda.gov.sa</p><p>Website: https://ade.sfda.gov.sa</p><p><strong>&nbsp;</strong></p><p>&middot; <u>Other GCC States: </u></p><p>Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are no data with regard to overdose.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: viral vaccines, hepatitis A, inactivated, whole virus ATC code: J07BC02</p><p>&nbsp;</p><p>VAQTA Paediatric is derived from hepatitis A virus that has been cultured in human MRC-5 diploid fibroblasts. It contains inactivated virus of a strain which was originally derived by further serial passage of a proven attenuated strain. The virus is grown, harvested, highly purified, formalin inactivated, and then adsorbed onto amorphous aluminium hydroxyphosphate sulfate.</p><p>&nbsp;</p><p><u>Mechanism of action</u></p><p>Hepatitis A vaccine elicits circulating neutralising antibodies to Hepatitis A virus sufficient to confer protection against the virus.</p><p>&nbsp;</p><p><u>Clinical efficacy and safety</u></p><p><em>Efficacy of VAQTA Paediatric: The Monroe Clinical Study</em></p><p>Clinical studies showed that the seroconversion rate in children approximately 12 months of age was 96% within 6 weeks after the recommended primary dose and that the seroconversion rate was 97% in children (22 years of age) and adolescents within 4 weeks after the recommended primary dose. The onset of seroconversion following a single dose of VAQTA Paediatric was shown to parallel the onset of protection against clinical hepatitis A disease. Protective efficacy has been demonstrated after a single dose of VAQTA Paediatric in 1,037 children and adolescents 2 to 16 years of age in a US community with recurrent outbreaks of hepatitis A (The Monroe Efficacy Study). Seroconversion was achieved in more than 99% of vaccine recipients within 4 weeks of the vaccination. The pre-exposure protective efficacy of a single dose of VAQTA Paediatric was observed to be 100% beginning 2 weeks after vaccination. A booster dose was administered to most vaccinees 6, 12, or 18 months after the primary dose. The effectiveness of VAQTA Paediatric for use in this community has been demonstrated by the fact that after 9 years, since the trial ended, there has been no case of hepatitis A disease in any vaccinee.</p><p>&nbsp;</p><p>Persistence of immunologic memory was demonstrated with an anamnestic antibody response to a booster dose given 6 to 18 months after the primary dose in children (22 years of age) and adolescents. To date, no cases of clinically confirmed hepatitis A disease 250 days after vaccination have occurred in these vaccinees from the Monroe Efficacy Study monitored for up to 9 years.</p><p>&nbsp;</p><p><em>Immunogenicity studies in children 12 through 23 months of age</em></p><p>In three combined clinical studies that assessed immunogenicity, 1,022 initially seronegative subjects received 2 doses of VAQTA Paediatric alone or concomitantly with other vaccines (combined diphtheria toxoid-tetanus toxoid- acellular pertussis and/or <em>Haemophilus influenzae </em>b and/or combined measles- mumps-rubella-varicella and/or combined measles-mumps-rubella and/or varicella and/or pneumococcal 7-valent conjugate vaccine). Seroconversion was achieved in 99.9% of initially seronegative subjects. No significant differences were observed when vaccines were given individually or concomitantly.</p><p>&nbsp;</p><p><em>Use in children with maternal antibody to hepatitis A</em></p><p>In a concomitant use study, children received VAQTA Paediatric (25 U) at approximately 12 months and approximately 18 months of age with or without other paediatric vaccines. After each dose of VAQTA Paediatric (25 U), the hepatitis A antibody titres were comparable between children who were initially seropositive to hepatitis A and children who were initially seronegative to hepatitis A. These data suggest that maternal antibody to hepatitis A in children approximately 12 months of age does not affect the immune response to VAQTA Paediatric.</p><p>&nbsp;</p><p><em>Antibody persistence</em></p><p>In studies of healthy children (22 years of age) and adolescents who received an initial 25 U dose of VAQTA Paediatric at Day 0 and a subsequent 25 U dose 6 to 18 months later, the hepatitis A antibody response to date has been shown to persist for at least 10 years. The geometric mean titres (GMTs) tend to decline over time. The GMTs declined over the first 5 to 6 years, but appeared to plateau through 10 years.</p><p>&nbsp;</p><p>Data available from long-term studies up to 10 years on the persistence of HAV antibodies after 2 doses of VAQTA in healthy, immunocompetent subjects up to 41 years of age allows prediction that based on mathematical modeling at least 99% of subjects will remain seropositive (&ge;10 mlU anti-HAV/mL) at least 25 years after vaccination.</p><p>&nbsp;</p><p>Based on this analysis, an additional vaccination following complete primary immunisation with 2 doses appears to be unnecessary. However, decisions regarding additional vaccination should be based on risk-benefit for the individual.</p><p>&nbsp;</p><p><em>Post-marketing safety study</em></p><p>In a post-marketing safety study, conducted at a large health maintenance organisation in the United States, a total of 12,523 individuals 2 through 17 years of age received 1 or 2 doses of VAQTA Paediatric. Safety was monitored by reviewing medical records that tracked emergency room and outpatient visits, hospitalisations and deaths. There was no serious, vaccine- related, adverse event identified among the 12,523 individuals in this study. There was no nonserious, vaccine-related, adverse event resulting in outpatient visits. There was no vaccine-related, adverse event identified that had not been reported in earlier clinical trials with VAQTA Paediatric.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Evaluation of pharmacokinetic properties is not required for vaccines.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No preclinical safety testing was performed using the vaccine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sodium borate Sodium chloride Water for injections</p><p>&nbsp;</p><p>For adjuvant and for information regarding residual components in trace quantities, see sections 2, 4.3 and 4.4.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store in a refrigerator (2&deg;C - 8&deg;C).</p><p>&nbsp;</p><p>DO NOT FREEZE since freezing destroys potency.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>0.5 mL suspension in a pre-filled syringe (type I glass) with plunger-stopper (chlorobutyl isoprene blend or bromobutyl).</p><p>&nbsp;</p><p>0.5 mL suspension in a pre-filled syringe (type I glass) with plunger-stopper (chlorobutyl isoprene blend or bromobutyl), without needle, with a tip-cap (chlorobutyl isoprene blend or bromobutyl isoprene blend), with 0, 1 or 2 separate needles.</p><p>&nbsp;</p><p>0.5 mL suspension in a vial (glass), grey rubber stopper (chlorobutyl isoprene blend).</p><p>&nbsp;</p><p>Pack sizes: Pack of 1 syringe or 1 vial.</p><p>&nbsp;</p><p>Not all pack sizes and presentations may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The vaccine should be used as supplied; no reconstitution is necessary.</p><p>&nbsp;</p><p>Parenteral drug products should be inspected visually for extraneous particulate matter and discolouration prior to administration. After thorough agitation, VAQTA Paediatric is a slightly opaque white suspension.</p><p>&nbsp;</p><p>Shake well immediately before use. Thorough agitation is necessary to maintain suspension of the vaccine. For syringe without attached needle, hold the syringe barrel and attach the needle by twisting in clockwise direction until the needle fits securely on the syringe.</p><p>&nbsp;</p><p>It is important to use a separate sterile syringe and needle for each individual to prevent transmission of infections from one person to another.</p><p>&nbsp;</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Marketing Authorisation Holder:
Merck Sharp & Dohme B.V.
Waarderweg 39, 2031 BN Haarlem, The Netherlands.

Manufacturer:
Merck Sharp & Dohme LLC., Sumneytown Pike, P.O. Box 4, West Point, PA, USA.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Dec 2022
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>